5α-reductase type 3 expression in human benign and malignant tissues: A comparative analysis during prostate cancer progression

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder

(2010) Vincent Cantagrel et al.   CELL

Chemoprevention of Prostate Cancer

(2010) Patrick C. Walsh   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Dutasteride on the Risk of Prostate Cancer

(2010) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

14-3-3  Amplifies Androgen Receptor Actions in Prostate Cancer

(2009) M. A. Titus et al.   CLINICAL CANCER RESEARCH

Increased Expression of Androgen Receptor Coregulator MAGE-11 in Prostate Cancer by DNA Hypomethylation and Cyclic AMP

(2009) A. R. Karpf et al.   MOLECULAR CANCER RESEARCH

Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer

(2008) J. A. Locke et al.   CANCER RESEARCH

Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth

(2008) R. B. Montgomery et al.   CANCER RESEARCH

Androgen Receptor Is Causally Involved in the Homeostasis of the Human Prostate Endothelial Cell

(2008) Alejandro Godoy et al.   ENDOCRINOLOGY

Site-specific Androgen Receptor Serine Phosphorylation Linked to Epidermal Growth Factor-dependent Growth of Castration-recurrent Prostate Cancer

(2008) Liliana A. Ponguta et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Phase II Study of Dutasteride for Recurrent Prostate Cancer During Androgen Deprivation Therapy

(2008) Satyan K. Shah et al.   JOURNAL OF UROLOGY

Oct4A is expressed by a subpopulation of prostate neuroendocrine cells

(2008) Paula Sotomayor et al.   PROSTATE